United States · 
Who invested in AmbAgon Therapeutics?
AmbAgon Therapeutics's investors include RA Capital Management, AbbVie and Mission BioCapital.
United States · Venture startup
Who invested in AmbAgon Therapeutics
Funding summaryUpdated 26 Oct 2026
$5.0Mraised across 1 round since 2025, from 1 source
- Latest round
- Venture, $5.0MFeb 2025
- Investors
- 3
The rounds
- Feb 2025Venture$5.0M
Source recordedSEC filing: $5.0M sold, first sale Jan 2025
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists AmbAgon Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about AmbAgon Therapeutics
How much has AmbAgon Therapeutics raised?
AmbAgon Therapeutics has raised $5.0M across 1 round since 2025.
When did AmbAgon Therapeutics last raise?
AmbAgon Therapeutics's most recent round was a Venture of $5.0M in Feb 2025.
What was AmbAgon Therapeutics's biggest round?
Its most recent round, $5.0M in Feb 2025, is also its largest on record.
Who backed AmbAgon Therapeutics first?
AmbAgon Therapeutics's first round on record, in Feb 2025, was backed by RA Capital Management, AbbVie and Mission BioCapital.
What stage is AmbAgon Therapeutics at?
AmbAgon Therapeutics's latest named round is a Venture, in Feb 2025.
Where is AmbAgon Therapeutics based?
AmbAgon Therapeutics is based in the United States.
Companies like AmbAgon Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.